Switching of H2-Receptor Antagonists to Over-the-Counter Status in Finland: Implications for Consumption and Adverse Effects

Author： Närhi Ulla  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.4, 2005-01, pp. : 243-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Over‐the‐Counter Status of Medicines

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 2, 2009-06 ,pp. : 91-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

Switching of Prescription Drugs to Over-the-Counter Status: Is it a Good Thing for the Elderly?

By Francis Sally-Anne  

Drugs & Aging, Vol. 22, Iss. 5, 2005-01 ,pp. : 361-370

Adis International

Access to resources Recommend Favorite

The Effect of Generic Competition on Prescription to Over-the-Counter Switching

By Hollenbeak C.S.  

PharmacoEconomics, Vol. 16, Iss. 6, 1999-12 ,pp. : 661-668

Adis International

Access to resources Recommend Favorite

Switching H2-antagonists to OTC status has failed to reduce the physician consultation rate

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 314, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Over-the-Counter Triptans for Migraine: What are the Implications?

By Tfelt-Hansen Peer  

CNS Drugs, Vol. 21, Iss. 11, 2007-01 ,pp. : 877-883

Adis International

Access to resources Recommend Favorite